Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study.
第一作者:
L,Frankenstein
第一单位:
University of Heidelberg, Heidelberg, Germany, Lutz.Frankenstein@med.uni-heidelberg.de.
作者:
医学主题词
肾上腺素能β受体拮抗剂(Adrenergic beta-Antagonists);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);临床试验(主题)(Clinical Trials as Topic);队列研究(Cohort Studies);数据库, 事实型(Databases, Factual);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);心力衰竭(Heart Failure);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);挪威(Norway);倾向性评分(Propensity Score);比例危险度模型(Proportional Hazards Models);螺内酯(Spironolactone);每搏输出量(Stroke Volume);治疗结果(Treatment Outcome)
DOI
10.1007/s00228-013-1512-x
PMID
23743778
发布时间
2021-10-21
- 浏览12
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



